1-9 of 9
Abraham S. Kanate
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 Registrational Study of Anitocabtagene Autoleucel for the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma: Preliminary Results from the IMMagine-1 Trial

Ciara Louise Freeman, Binod Dhakal, Gurbakhash Kaur, Richard T. Maziarz, Natalie Callander, Adam S. Sperling, Carolina Schinke, Andrzej J Jakubowiak, Noa Biran, Douglas W Sborov, Cindy Varga, Abhinav Deol, Abraham S. Kanate, Mehmet Hakan Koçoğlu, Melhem M. Solh, Kamalika Banerjee, Rebecca Chan, Myrna Nahas, Ana Kostic, Enrique Granados, Carolyn Jackson, Christopher R. Heery, Tim Welliver, Krina K. Patel, Matthew Frigault
Journal: Blood
Blood (2024) 144 (Supplement 1): 1031.
https://doi.org/10.1182/blood-2024-198499
Published: 2024
Journal Articles

Haploidentical Vs. Matched Unrelated Donor Transplants Using Post-Transplant Cyclophosphamide for Lymphoma: A Joint CIBMTR/EBMT Study

Alberto Mussetti, Abraham S. Kanate, Tao Wang, Meilun He, Mehdi Hamadani, Hervé Finel, Sr., Ariane Boumendil, Sr., Bertram Glass, Luca Castagna, Didier Blaise, Steven G.E. Marsh, Sophie Paczesny, Shahinaz M. Gadalla, Peter Dreger, Stephen R. Spellman, Stephanie J. Lee, Yung-Tsi Bolon, Anna Sureda
Journal: Blood
Blood (2021) 138 (Supplement 1): 174.
https://doi.org/10.1182/blood-2021-151197
Published: 2021
Journal Articles

Health-Related Quality of Life Among Patients with Relapsed or Refractory Multiple Myeloma Who Received Pomalidomide, Bortezomib, and Low-Dose Dexamethasone Versus Bortezomib and Low-Dose Dexamethasone - Results from the Phase 3 Optimismm Study

Katja Weisel, MD, Meletios A Dimopoulos, MD, Philippe Moreau, Munci Yagci, Alessandra Larocca, MD, Abraham S. Kanate, MD, Filiz Vural, Nicola Cascavilla, MD, Supratik Basu, MBBS, MD FRCP, FRCPath, Peter Johnson, Peter D. Byeff, MD, Marek Hus, Paula Rodriguez Otero, MD, Kosei Matsue, MD PhD, Ercan Muelduer, Pekka Anttila, MD, Patrick Hayden, Maria-Theresa Krauth, MD, Dina Ben-Yehuda, MD, Larisa P. Mendeleeva, MD PhD Prof, Shien Guo, Lea Purnomo, Xin Yu, Lara Grote, Tsvetan Biyukov, MD, Mohamed Zaki, MD PhD, Paul Richardson
Journal: Blood
Blood (2018) 132 (Supplement 1): 1960.
https://doi.org/10.1182/blood-2018-99-112155
Published: 2018
Journal Articles

Lenalidomide and Low Dose Dexamethasone in Previously Treated Multiple Myeloma Patients with Impaired Renal Function: Efficacy Analysis of PrE1003, a Precog Study

Joseph Mikhael, MD, Judi Manola, Sagar Lonial, MD FACP, Brendan M Weiss, MD, Kurt Oettel, MD, Suzanne R. Hayman, MD, Abraham S. Kanate, MD, S. Vincent Rajkumar, MD
Journal: Blood
Blood (2016) 128 (22): 5712.
https://doi.org/10.1182/blood.V128.22.5712.5712
Published: 2016
Journal Articles

Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors

Clinical Trials & Observations
Abraham S. Kanate, Alberto Mussetti, Mohamed A. Kharfan-Dabaja, Kwang W. Ahn, Alyssa DiGilio, Amer Beitinjaneh, Saurabh Chhabra, Timothy S. Fenske, Cesar Freytes, Robert Peter Gale, Siddhartha Ganguly, Mark Hertzberg, Evgeny Klyuchnikov, Hillard M. Lazarus, Richard Olsson, Miguel-Angel Perales, Andrew Rezvani, Marcie Riches, Ayman Saad, Shimon Slavin, Sonali M. Smith, Anna Sureda, Jean Yared, Stefan Ciurea, Philippe Armand, Rachel Salit, Javier Bolaños-Meade, Mehdi Hamadani
Journal: Blood
Blood (2016) 127 (7): 938–947.
https://doi.org/10.1182/blood-2015-09-671834
Published: 2016
Includes: Supplemental data
Journal Articles

Cost and Efficacy of Upfront Plerixafor Versus a “Just-in-Time” (JIT) Approach in Hematopoietic Progenitor Cell (HPC) Mobilization

Lauren Westfall Veltri, MD, Aaron Cumpston, PharmD, Alexandra Shillingburg, PharmD, Christopher Lipinski, Sijin Wen, PhD, Sonia Leadmon, Kathy Watkins, MT, Lab Technician, Michael David Craig, MD, Mehdi Hamadani, MD, Abraham S. Kanate, MD
Journal: Blood
Blood (2014) 124 (21): 1127.
https://doi.org/10.1182/blood.V124.21.1127.1127
Published: 2014
Journal Articles

Higher Infused CD34+ Cell Dose Improves Survival In Patients Undergoing In Vivo T-Cell Depleted, but Not T-Cell Replete Peripheral Blood Hematopoietic Cell Transplant

Abraham S Kanate, MD, Salman Osman, MD, Aaron Cumpston, PharmD, Gerry Hobbs, PhD, Sonia Leadmon, BS, Pamela Bunner, BS, Kathy Watkins, MT, Laura Gibson, PhD, William Tse, MD, Jame Abraham, MD, FACP, Scot Remick, MD, FACP, Michael Craig, MD, Sayed Mehdi Hamadani, MD
Journal: Blood
Blood (2010) 116 (21): 1272.
https://doi.org/10.1182/blood.V116.21.1272.1272
Published: 2010
Journal Articles

In Vivo T-Cell Depletion Does Not Improve Rates of Graft-Versus-Host Disease and Transplantation Outcomes In Patients Undergoing Peripheral Blood Hematopoietic Cell Transplant.

Abraham S Kanate, MD, Salman Osman, MD, Aaron Cumpston, PharmD, Gerry Hobbs, PhD, Sonia Leadmon, BS, Pamela Bunner, BS, Laura Gibson, PhD, William Tse, MD, Jame Abraham, MD, FACP, Scot Remick, MD, FACP, Michael Craig, MD, Sayed Mehdi Hamadani, MD
Journal: Blood
Blood (2010) 116 (21): 4536.
https://doi.org/10.1182/blood.V116.21.4536.4536
Published: 2010
Journal Articles

Effect of T-Cell Dose On Outcomes After Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Hematological Malignancies.

Abraham S Kanate, MD, Farhad Khimani, MD, Aaron Cumpston, PharmD, Kathy Watkins, BS, Sonia Leadmon, BS, Michael D Craig, MD
Journal: Blood
Blood (2009) 114 (22): 1171.
https://doi.org/10.1182/blood.V114.22.1171.1171
Published: 2009